The Latest Cardiac and Vascular News
SALT LAKE CITY–(BUSINESS WIRE)–SignPath Pharma (Salt Lake City UT) today announced the first commercial out-license of its proprietary CorreQT technology platform. SignPath entered into an agreement with Rain Therapeutics (Newark CA), which licenses SignPath’s CorreQT technology for use in conjunction with Rain’s proprietary lead compound, Tarlox® (tarloxotinib,) a potent pan-ErbB […]
WALTHAM, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) — Proteon Therapeutics, Inc. (“Proteon” or the “Company”) (Nasdaq: PRTO), a company that has historically focused on the development of novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular disease, today announced its financial results for the quarter ended September […]
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported second quarter fiscal 2020 revenue of $205.0 million, an increase of 13% compared to revenue of $181.8 million for the same period of fiscal 2019. Operating income was $60.2 million, up 20%, compared […]
WAYNE, Pa., Oct. 31, 2019 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 16, 2019 to shareholders of record at the close of business on […]
Q3 2019 worldwide revenue of $243.0 million, up 9.6% as reported over Q3 2018 Q3 2019 core revenue on a comparable, constant currency basis* up 4.3% over Q3 2018 Q3 2019 GAAP loss per share was $(0.06), compared to GAAP EPS of $0.30 in Q3 2018 Q3 2019 non-GAAP EPS* […]
Los Angeles, CA, Oct. 31, 2019 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”) today announced that it had filed a preliminary information statement with respect to a proposed a reverse stock split of its common stock at a ratio of between 1 for 100 and […]
ATLANTA, Oct. 30, 2019 /PRNewswire/ — Third Quarter and Recent Business Highlights: Total revenues were $67.9 million in the third quarter of 2019, reflecting year over year growth of 5% and a 6% increase on a non-GAAP constant currency basis, both compared to the third quarter of 2018 On-X® revenues increased 12%, and 12% on […]
COPENHAGEN, Denmark, Oct. 31, 2019 /PRNewswire/ — CathVision ApS, a medical device company developing, manufacturing and selling cardiac electrophysiology products, has been awarded a competitive EU grant of 2.2M Euro for the clinical development of its software and clinical decision support platform. The EU grant is for an SME Instrument, Phase 2 under the Horizon2020 […]
SUNNYVALE, Calif., Oct. 29, 2019 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2019. “Our third quarter results reflect strong execution across our entire organization,” […]
– Revenue increased 45% year over year to $11.8 million – Orders increased 95% year over year – Net income $2.0 million; Diluted EPS $0.06 – Adjusted EBITDA $2.8M – Thirteenth consecutive quarter of positive net income ENGLEWOOD, Colo., Oct. 29, 2019 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing […]
